I use this guide to help research teams, procurement professionals, and pharmaceutical-intermediate buyers evaluate 3'-Amino-2'-hydroxybiphenyl-3-carboxylic Acid, CAS 376592-93-7. The compound contains a biphenyl framework with amino, hydroxy, and carboxylic acid functionality, making identity confirmation and impurity control important before development or scale-up. As Maison Chemical, we can support product inquiries, documentation review, sample discussions, and supply planning for qualified buyers. Because commercial specifications may vary by batch and application, I recommend confirming the current specification, analytical data, packaging, and availability before placing an order.
Please visit our website for more information on this topic.
This guide is intended for pharmaceutical and specialty-chemical companies screening aromatic intermediates for research, process development, or manufacturing. It is also useful for purchasing teams comparing suppliers of CAS 376592-93-7 and preparing an internal qualification checklist. I focus on the practical questions that normally affect a purchase: identity, purity, analytical documentation, packaging, logistics, and supplier responsiveness. The information below is a procurement framework rather than a substitute for application-specific technical validation.
3'-Amino-2'-hydroxybiphenyl-3-carboxylic Acid is identified by CAS Number 376592-93-7 and its systematic chemical name. Its structure includes two aromatic rings connected through a biphenyl bond, together with one amino group, one hydroxy group, and one carboxylic acid group. These functional groups can influence solubility, salt formation, reaction compatibility, and analytical behavior. Buyers should therefore evaluate the material using the exact intended synthetic route rather than relying only on the product name.
The name and CAS number are useful starting points, but they should not be treated as the complete quality record. Before approving a source, I recommend requesting a Certificate of Analysis, Safety Data Sheet, batch or lot information, and a clear description of the analytical methods used. If the material is intended for a regulated development program, the buyer should also define documentation expectations before the first commercial discussion. This approach reduces the risk of purchasing a material that is chemically similar but unsuitable for the intended process.
R&D material is generally purchased for route scouting, reaction screening, analytical method development, or small-scale synthesis. At this stage, the most important factors are confirmed identity, adequate purity for the experiment, traceability, and a usable sample quantity. A buyer may begin with a sample in the range of 100 mg to 1 g, depending on the number of experiments planned. The exact quantity should be selected from the project’s material balance rather than assumed from a standard catalog format.
Process-development material must support repeatable experiments and provide enough information to evaluate impurity behavior. In addition to assay, the buyer may need related-substance data, water content, residual-solvent information, and a description of the analytical method. An internal acceptance example could be a purity target of at least 98.0% by the agreed method, but this is only a buyer-defined example and is not a claimed specification for every lot of CAS 376592-93-7. The correct limit should be established according to the downstream reaction and the customer’s quality system.
Manufacturing-oriented purchasing requires more than a single successful sample. Buyers should assess batch consistency, production capacity, change-control practices, packaging suitability, export documentation, and the supplier’s ability to communicate deviations. If a water limit is important to the process, a buyer might define an example criterion such as not more than 1.0% water by Karl Fischer analysis, subject to method validation and process needs. Maison Chemical can discuss these requirements with customers before quotation so that the commercial proposal reflects the actual project scope.
The compound may be considered as an aromatic building block or pharmaceutical intermediate when its three functional groups fit the planned synthetic sequence. The amino group may participate in coupling or derivatization chemistry, while the carboxylic acid can support amide formation or other transformations. The hydroxy group may affect regioselectivity, protection strategy, intermolecular interactions, and purification. These are structural considerations, not guarantees of performance in a particular reaction.
For application matching, I recommend sharing the proposed reaction type, target scale, solvent system, temperature range, and impurity sensitivity with the supplier. For example, a material acceptable for early discovery may not be appropriate for a route requiring tight control of positional isomers or residual solvents. Buyers should also check whether the free-acid form is required or whether a salt, protected derivative, or custom intermediate would be more practical. The supplier should confirm what form is actually available rather than assuming that all related forms are interchangeable.
Start by matching the product name and CAS Number 376592-93-7 with the requested structure and intended chemical form. Ask whether the offered material is the free acid, a salt, a solvate, or another physically modified form. Review the molecular structure, appearance description, batch number, and analytical identifiers supplied by the vendor. If the buyer has a target structure or internal code, it should be sent with the inquiry to prevent naming ambiguity.
Maison Chemical are exported all over the world and different industries with quality first. Our belief is to provide our customers with more and better high value-added products. Let's create a better future together.
Next, separate mandatory specifications from preferred specifications. Mandatory items may include identity confirmation, assay or purity, related substances, water, residual solvents, heavy metals, and packaging conditions, depending on the application. I recommend specifying the analytical technique, reporting basis, and acceptance limits instead of asking only for “high purity.” This creates a measurable comparison between suppliers and helps prevent misunderstandings during quotation.
Request one current COA for the available lot and verify that the document includes the lot number, test date, methods, results, and release status. The SDS should correspond to the same substance and provide handling, storage, transport, and hazard information. For a regulated project, ask whether additional documents such as a specification sheet, declaration of origin, or change-notification process are available. The required document package should be agreed before purchase, especially when the material will enter a customer’s quality-controlled facility.
Commercial quantity should be based on the synthesis plan, expected yield, sampling needs, and possible repeat experiments. A practical purchasing plan may separate an initial sample, a pilot quantity, and a later production order instead of committing to the largest quantity immediately. Packaging should protect the material from contamination and support safe handling during storage and transport. The buyer should confirm net weight, container type, labeling, shipping terms, destination regulations, and whether temperature or moisture controls are required.
Pricing for a specialty intermediate usually depends on quantity, specification, analytical requirements, packaging, production status, and destination. A sample price should not be used as a direct predictor of kilogram-scale pricing, because packaging and testing costs may have a greater effect at small quantities. Minimum order quantity also varies by whether the material is available from stock, requires production, or requires a customized specification. I recommend requesting a tiered quotation for at least three levels, such as sample, pilot, and commercial quantity, when the project is still being evaluated.
Lead time should be confirmed in writing for the specific lot and quantity rather than inferred from a general catalog page. Buyers should ask whether the quoted lead time begins after purchase-order confirmation, technical approval, or payment. It is also useful to clarify whether the schedule includes testing, packing, export documents, and transit. Maison Chemical can review the requested quantity and destination with the customer to provide a more realistic supply discussion.
I also recommend comparing suppliers on communication quality, not only on price. A low quotation may create additional cost if the COA is incomplete, the analytical method is unclear, or the shipment does not match the approved specification. For important projects, buyers can qualify a supplier through document review, sample testing, and comparison of results from multiple lots when available. A three-lot review may provide more useful information about consistency than a single successful sample, although the appropriate qualification depth depends on the customer’s quality system.
One common mistake is ordering by name alone without confirming the exact structure and form. Another is treating a stated purity value as meaningful without checking the test method, impurity profile, and reporting basis. Buyers may also overlook the difference between material availability and confirmed production capacity. Finally, waiting until shipment to request documents can delay receiving, testing, and release at the customer’s facility.
At Maison Chemical, we approach inquiries for 3'-Amino-2'-hydroxybiphenyl-3-carboxylic Acid CAS 376592-93-7 as technical purchasing projects rather than simple price requests. We can review the required quantity, target specification, application stage, packaging expectations, and destination before discussing supply. Our role is to help buyers identify the information needed for a responsible evaluation, while the customer remains responsible for confirming suitability in its own process. Availability, MOQ, lead time, and documentation should be confirmed for each individual inquiry.
For this product, the best purchasing decision begins with identity confirmation and a clearly defined quality profile. I recommend requesting the structure or internal specification, intended quantity, application stage, required documents, and destination in the first inquiry. Then compare suppliers using the same criteria for analytical data, lot traceability, packaging, price, MOQ, and lead time. This process gives procurement and technical teams a more reliable basis for approving CAS 376592-93-7.
To begin a discussion with Maison Chemical, send the required quantity, target purity, preferred analytical methods, packaging needs, and delivery location. We can then review the inquiry and respond with the applicable product information, commercial options, and documentation available for the requested supply. This is the most efficient next step when you need a dependable pharmaceutical-intermediate supplier without committing to an unsuitable specification.
Are you interested in learning more about 3'-Amino-2'-hydroxybiphenyl-3-carboxylic Acid CAS 376592-93-7? Contact us today to secure an expert consultation!